Literature DB >> 17057344

Molecular complementarity between tetracycline and the GTPase active site of elongation factor Tu.

Susan E Heffron1, Suet Mui, Annette Aorora, Kenton Abel, Ernst Bergmann, Frances Jurnak.   

Abstract

Two crystal forms of a complex between trypsin-modified elongation factor Tu-MgGDP from Escherichia coli and the antibiotic tetracycline have been solved by X-ray diffraction analysis to resolutions of 2.8 and 2.1 A, respectively. In the P2(1) form, cocrystals were grown from a solution mixture of the protein and tetracycline. Six copies of the trypsin-modified EF-Tu-MgGDP-tetracycline complex are arranged as three sets of dimers in the asymmetric unit. In the second crystal form, tetracycline was diffused into P4(3)2(1)2 crystals, resulting in a monomeric complex in the asymmetric unit. Atomic coordinates have been refined to crystallographic R factors of 18.0% for the P2(1) form and 20.0% for the P4(3)2(1)2 form. In both complexes, tetracycline makes significant interactions with the GTPase active site of EF-Tu. The phenoldiketone moiety of tetracycline interacts directly with the Mg(2+), the alpha-phosphate group of GDP and two amino acids, Thr25 and Asp80, which are conserved in the GX(4)GKS/T and DX(2)G sequence motifs found in all GTPases and many ATPases. The molecular complementarity, previously unrecognized between invariant groups present in all GTPase/ATPases and the active moiety of tetracycline, may have wide-ranging implications for all drugs containing the phenoldiketone moiety as well as for the design of new compounds targeted against a broad range of GTPases or ATPases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057344     DOI: 10.1107/S0907444906035426

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  The conserved GTPase HflX is a ribosome splitting factor that binds to the E-site of the bacterial ribosome.

Authors:  Mackenzie L Coatham; Harland E Brandon; Jeffrey J Fischer; Tobias Schümmer; Hans-Joachim Wieden
Journal:  Nucleic Acids Res       Date:  2016-01-04       Impact factor: 16.971

2.  Specific binding of divalent metal ions to tetracycline and to the Tet repressor/tetracycline complex.

Authors:  Gottfried J Palm; Thomas Lederer; Peter Orth; Wolfram Saenger; Masayuki Takahashi; Wolfgang Hillen; Winfried Hinrichs
Journal:  J Biol Inorg Chem       Date:  2008-06-12       Impact factor: 3.358

3.  Structural basis for specific, high-affinity tetracycline binding by an in vitro evolved aptamer and artificial riboswitch.

Authors:  Hong Xiao; Thomas E Edwards; Adrian R Ferré-D'Amaré
Journal:  Chem Biol       Date:  2008-10-20

4.  Tetracycline does not directly inhibit the function of bacterial elongation factor Tu.

Authors:  Katherine E Gzyl; Hans-Joachim Wieden
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

5.  Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells.

Authors:  Eric Macia; Monserrat Vazquez-Rojas; Alessia Robiolo; Racha Fayad; Sophie Abélanet; Isabelle Mus-Veteau; Fabien Fontaine-Vive; Mohamed Mehiri; Frédéric Luton; Michel Franco
Journal:  Molecules       Date:  2021-02-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.